(2026). Acquired Autoimmune Factor XIII Deficiency as a Novel Immune‐Related Adverse Event of Combined Ipilimumab and Nivolumab Therapy for Renal Cell Carcinoma: A Case Report. IJU Case Reports.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Acquired Autoimmune Factor XIII Deficiency as a Novel Immune‐Related Adverse Event of Combined Ipilimumab and Nivolumab Therapy for Renal Cell Carcinoma: A Case Report."
IJU Case Reports 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Acquired Autoimmune Factor XIII Deficiency as a Novel Immune‐Related Adverse Event of Combined Ipilimumab and Nivolumab Therapy for Renal Cell Carcinoma: A Case Report."
IJU Case Reports, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.